JPM Week 2027 · San Francisco

Meet us at JPM

One nitric oxide platform. Multiple potential indications.

Let’s connect

Explore what we can build together.

NOxy is advancing a topical nitric oxide platform, led by NOX1416, with a primary focus on deep tissue pressure injuries and expansion into inflammatory dermatology, including vulvar lichen sclerosus.

We welcome conversations with investors and strategic partners who see the opportunity to advance multiple indications through a shared platform.

Request a meeting

Tell us a little about yourself and what you would like to discuss.

We will use these details to respond to your meeting request. Privacy